Orthogonal Gene Engineering Enables CD8+ T Cells to Control Tumors through a Novel PD-1+TOX-indifferent Synthetic Effector State
暂无分享，去创建一个
G. Coukos | S. Carmona | P. Romero | M. Andreatta | C. Jiménez-Luna | C. Ronet | Wilson Castro | M. Irving | L. Scarpellino | S. Luther | E. Stefanidis | Bili Seijo | E. Lanitis | J. Corria-Osorio | Tania Muller | Y. Ortiz-Miranda | A. Spill | B. Seijo